FBLG stock news
This page provides real-time market news, earnings updates, and company announcements related to FibroBiologics, Inc. (FBLG).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-14 04:03 EST
FibroBiologics Granted Extension by Nasdaq to Regain Compliance
Finviz2026-02-23 13:34:18
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
FibroBiologics to Present at the BIO Investment & Growth Summit
Finviz2026-02-26 13:33:09
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
Finviz2026-03-05 13:33:08
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
Finviz2026-03-12 12:33:47
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Finviz2026-03-02 13:33:44
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
Finviz2026-03-05 13:33:08
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
Finviz2026-03-12 12:33:47
FBLG stock chart
FBLG stock detailsFBLG stock price change
On the last trading day, FBLG stock closed at 0.34 USD, with a price change of -0.03% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more